Alternatives to CoreAge Rx

$99/mo semaglutide, $183/mo tirzepatide, all 50 states, a named physician personally reviewing every intake, and a real 5-7 day timeline — on a broader peptide platform where GLP-1 pricing is genuinely invisible unless you know to pull the page's own data bundle.

Compounded semaglutide at $69 a month and tirzepatide at $119, one flat price that SnagRx says covers the medication, the supplies, the doctor review and shipping, with no membership fee and cancellation by email or phone. Both figures are advertised against struck-through list prices of $299 and $399 under a live countdown clock, and the promise to lock that rate for life is marketing rather than a published term. It ships from licensed US pharmacies it never names, and publishes no list of the states it serves.

Both prices came down since our last check: read live on 2026-08-26 the catalog reads from $79 a month for compounded semaglutide and from $159 for tirzepatide, against $99 and $169 in July. Same price at every dose is stated beside them, so titrating up does not raise the bill — but from is a floor and no ceiling or dose ladder is published anywhere. One question this record used to leave open is now answered on the site itself: yourEra says its clinician network is licensed in all 50 states, and repeats it in a badge and in its own founding story. The single price covers the telehealth visit, the medication, injection supplies, dose adjustments, unlimited messaging and shipping. Two things belong on your list before you pay. The refund policy stops refunds the moment the pharmacy begins preparing your order, whether or not it has shipped. And the Terms require you to have a device with a working video camera, which is the closest the site comes to telling you whether a live visit is part of this.

Flat at every dose - $99 semaglutide, $134 tirzepatide, all fifty states - which makes the annual math trivial. The site never names its operating company.

FDA warning letter #721472 (Feb. 2026), which names newself.com. A flat, dose-independent price for both molecules — $99.97/mo semaglutide, $144.49/mo tirzepatide, same price at every dose — nationwide, though it requires 3 months upfront.

For a working mother the appeal here is logistics as much as money: a fully online intake with no video call to schedule, all 50 states, and one flat charge per month that covers the visit, the plan, the medication and shipping — held at the same price whatever dose you end up on. Month to month that is $79 for compounded semaglutide and $109 for compounded tirzepatide; the $69 the homepage headlines under a countdown timer is the twelve-month tier, and $95 is its tirzepatide equivalent. Flat-by-dose is the part that actually protects a budget, because dose-priced providers routinely double between a starting and a maintenance dose. Two things to weigh against that. The off-ramp is narrow: subscriptions auto-renew, canceling means emailing care@leanmeds.com at least 48 hours before the processing date, and the order stops being refundable the moment you submit the medical intake. And the operator named throughout its own Terms — Trinity HealthCare Supply, LLC — is the company FDA wrote to on 8 June 2026 under its other brand, altRx, for labeling compounded vials with its own name when it was not the compounder and for calling compounded GLP-1s 'clinically proven.' That letter concerns altrx.com, not this site, but it is the same legal entity at the same Miami suite, and no pharmacy or clinician is named here either.

Compounded semaglutide at $79 a month and tirzepatide at $119, month to month, with no dose-based increase and — checked in its own checkout data rather than taken on trust — a renewal price identical to the joining price. That last part is rarer than it should be. Two things the homepage will not tell you. The $49 and $99 it advertises are the twelve-month totals divided by twelve, not a monthly rate you can start on, and the countdown beside them is not a real deadline: it read August 15th and then August 20th within the same hour. The larger caveat is corporate. NextMeds is operated by Trinity HealthCare Supply, LLC, which also runs Lean Meds, altRx and Trinity Meds, and that operator holds an open FDA warning letter.

Pepti publishes the lowest semaglutide price in this entire roster — $99 a month, flat at every titration dose, with the medication, physician review, shipping, refill management and unlimited messaging with your prescribing doctor all inside it. Tirzepatide is $199 on the same all-in, flat-at-every-dose basis. That number is low enough to deserve skepticism, so it is worth saying exactly where it comes from: Pepti states it on a dedicated cost page, repeats it in its FAQ ('we keep pricing flat and transparent at $99/mo all-in'), and prices the comparison against Hims, Henry Meds and Mochi on the same page. It names two prescribing physicians and says its medication is compounded by FDA-registered 503A or 503B pharmacies, though it never names which. The real limits are reach and format: it ships to 36 states rather than 50, it is cash-pay only and bills no insurance, and its needle-free oral GLP-1/GIP drops cost $349 — well above its own injection.

$99 semaglutide, $149 tirzepatide, flat at every dose, all 50 states. Renewal prices match advertised prices in the checkout data, so the no-price-rise claim holds. A plan month is four weeks; the '12-month' plan at $999 is 48 weeks. Same operator as Lean Meds, altRx and NextMeds — one company, four storefronts — and that operator holds FDA letter 728236, still open.